Jeffrey Cole's most recent trade in Cadrenal Therapeutics Inc was a trade of 25,000 Stock Options done . Disclosure was reported to the exchange on Jan. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cadrenal Therapeutics Inc | Jeffrey Cole | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 25,000 | 25,000 | - | - | Stock Options | |
| Cadrenal Therapeutics Inc | Jeffrey Cole | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 150,000 | 150,000 | - | - | Stock Options |